IDO2 and cancer: The expression of IDO2 in cancer cells could be of pivotal importance in driving the immune response against cancer in the context of an intriguing mechanism described by Sørensen et al. [66], who demonstrated the existence of spontaneous cytotoxic T lymphocyte reactivity against IDO2 in the peripheral blood of cancer patients.